MIT researchers have discovered a new family of viruses in the ocean that appears to play a key role in ocean ecosystems and could help provide insights on how viruses evolve, reports Marin Finucane for The Boston Globe. Finucane explains that the findings could also lead to, "a better understanding of human biology.”
Boston Magazine reporter Hayley Glatter spotlights how two MIT seniors - Mary Clare Beytagh and Matthew Chun - were among this year’s winners of the Rhodes Scholarship.
Boston Globe reporter Alyssa Meyers writes that MIT researchers have observed how the flu spreads between cells in the body. “Once it’s infected a cell and has commandeered its inner workings, the virus makes copies of itself that gather into buds attached to the membrane. The buds then break free from their host and go on to infect other cells.”
Boston Magazine reporter Jamie Ducharme writes that MIT researchers have developed a non-invasive technique for assessing cells, which could eventually be used to help diagnose diseases. The researchers are “working with doctors at Massachusetts General Hospital, who hope to use the technique to study diseases such as cancer and asthma.”
Nature reporter Anna Nowogrodzki spotlights Prof. Aviv Regev’s quest to map every cell in the human body. “One of the things that makes Aviv special is her enormous bandwidth. I've never met a scientist who thinks so deeply and so innovatively on so many things,” says Dana Pe'er, a computational biologist at Memorial Sloan Kettering Cancer Center.
During a panel discussion during the Koch Institute’s 16th Annual Cancer Research Symposium, participants discussed how the convergence of biology and engineering could accelerate treatments for cancer and other diseases, writes Robert Weisman for the Boston Globe. “To my mind, this is the 21st century’s innovation story,” said President Emerita Susan Hockfield.
Xconomy reporter Ben Fidler writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation who died at age 71. Institute Prof. Phillip Sharp explains that Termeer was, “a transformational leader in biotechnology of orphan diseases. Many children now have hope of a healthy life because of his vision and 40 years of creative business leadership.”
Prof. Eric Lander, founding director of the Broad Institute, writes for The Washington Post about the importance of federal funding for scientific research, noting that scientific advances help drive the American economy. “When scientific breakthroughs spawn new industries and jobs, those benefits occur right here in the United States,” Lander explains.
STAT reporter Kate Sheridan spotlights the 2017 Koch Institute Image Awards, which aim to recognize visual images produced through life sciences and biomedical research. Sheridan notes that the competition shows “everyone how beautiful biology can be — no microscope required.”
Science reporter Elizabeth Pennisi spotlights Institute Professor Sallie “Penny” Chisholm’s pioneering research into uncovering the secrets of Prochlorococcus. Prof. Michael Follows says that Chisholm, "has beautifully shown us how this microbe works and how the ocean world is organized."
MIT researchers have developed a cost-effective, cell analysis method using graphene sheets, reports Brooks Hays for UPI. The new technique could allow “simple sheets of graphene oxide to function as a diagnostics device for medical and biological tests,” Hays explains.
Boston Herald reporter Jordan Graham writes that a committee co-chaired by Prof. Richard Hynes has made a series of recommendations for the use of gene editing in humans. Graham explains that the committee recommended “leaving the door open to altering the human genome in ways that would affect the descendants of patients with hereditary diseases and disabilities.”
A committee co-chaired by Prof. Richard Hynes has presented a set of guidelines for using the CRISPR gene-editing tool in humans, reports Lauran Neergaard for the AP. Neergaard writes that Hynes noted, “safety is one reason for caution, as scientists will have to learn whether editing one gene has unwanted downstream effects.”
Washington Post reporter Joel Achenbach writes that a committee co-chaired by Prof. Richard Hynes has presented a series of guidelines for applying CRISPR gene editing in humans. “We say proceed with all due caution, but we don’t prohibit germline, after considerable discussion and debate,” says Hynes. “We’re talking only about fixing diseases.”
Prof. Bob Weinberg of the Whitehead Institute spoke with Karen Weintraub at WBUR about the best ways to prevent cancer. Reducing obesity and smoking will lead to “decreases in cancer mortality, at least over the next decade or two, that dwarf anything I and my colleagues can produce in terms of new, miraculous cures,” he said.